Officials in California criticized the federal response to a bio lab found in a Fresno County suburb after a similar setup was found at a home in Las Vegas over the weekend. The California lab was ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Pasig City Mayor Vico Sotto once again charmed the internet with his candid humor after leaving a comment on the Pasig City Public Information Office’s Facebook post. The PIO had shared photos from ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Start by making a list of the devices and appliances you need to power and add up the ...

Founders: Benjamine Liu (CEO), Linhao Zhang Launched: 2016 Headquarters: New York City Funding: $600 million Valuation: $1.7 billion (PitchBook) Key Technologies: Artificial intelligence, deep neural ...

Text to image AI art generator apps are in high demand! So today I show you how to use Playground AI, with a Playground AI demo prompt tutorial. It's 100% free and is really easy to use. You are ...

Mention offers an online toolkit of free social media generators. These make it easy to create posts, captions and bios for different platforms in just a few clicks. Built on GPT-3.5, the web-based ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

The school sitcom has found new life on Netflix after being canceled not once but twice during its original run Ron Batzdorff/NBCU Photo Bank/NBCUniversal via Getty A.P. Bio may have been canceled two ...

Callum is a seasoned gaming managing editor for a number of publications and a gamer who will always try to shine a spotlight on indie games before giving AAA titles the time of day. He loves nothing ...

Novartis has had some bad luck with bispecific antibodies in the past, but judging by the pharma's latest deal it still has faith in the modality. Under the terms of this partnership, Bay Area-based ...